Vaxart, Inc. Files 8-K on Financials and Operations
Ticker: VXRT · Form: 8-K · Filed: Mar 21, 2025 · CIK: 72444
| Field | Detail |
|---|---|
| Company | Vaxart, Inc. (VXRT) |
| Form Type | 8-K |
| Filed Date | Mar 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, operations, company-history
Related Tickers: VXRT
TL;DR
Vaxart dropped an 8-K detailing financials - check it for the latest on operations.
AI Summary
Vaxart, Inc. filed an 8-K on March 20, 2025, reporting on its results of operations and financial condition, and providing financial statements and exhibits. The filing details the company's status as a biological products manufacturer, previously known as Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., and NABI BIOPHARMACEUTICALS.
Why It Matters
This filing provides an update on Vaxart's financial health and operational status, which is crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) and does not appear to contain any new material events or significant negative news.
Key Players & Entities
- Vaxart, Inc. (company) — Registrant
- March 20, 2025 (date) — Date of earliest event reported
- Aviragen Therapeutics, Inc. (company) — Former company name
- Biota Pharmaceuticals, Inc. (company) — Former company name
- NABI BIOPHARMACEUTICALS (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- 001-35285 (filing_id) — SEC File Number
FAQ
What specific financial information is being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported was on March 20, 2025.
What are the previous names of Vaxart, Inc.?
Vaxart, Inc. was formerly known as Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., and NABI BIOPHARMACEUTICALS.
In which state is Vaxart, Inc. incorporated?
Vaxart, Inc. is incorporated in Delaware.
What is the primary business of Vaxart, Inc. according to the SIC code?
Vaxart, Inc. is classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' with SIC code [2836].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 21, 2025 regarding Vaxart, Inc. (VXRT).